These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 338576)
1. Genetics of nitrofurazone resistance in Escherichia coli. McCalla DR; Kaiser C; Green MH J Bacteriol; 1978 Jan; 133(1):10-6. PubMed ID: 338576 [TBL] [Abstract][Full Text] [Related]
2. Oxygen-insensitive nitroreductases: analysis of the roles of nfsA and nfsB in development of resistance to 5-nitrofuran derivatives in Escherichia coli. Whiteway J; Koziarz P; Veall J; Sandhu N; Kumar P; Hoecher B; Lambert IB J Bacteriol; 1998 Nov; 180(21):5529-39. PubMed ID: 9791100 [TBL] [Abstract][Full Text] [Related]
3. Study of the role played by NfsA, NfsB nitroreductase and NemA flavin reductase from Escherichia coli in the conversion of ethyl 2-(2'-nitrophenoxy)acetate to 4-hydroxy-(2H)-1,4-benzoxazin-3(4H)-one (D-DIBOA), a benzohydroxamic acid with interesting biological properties. Valle A; Le Borgne S; Bolívar J; Cabrera G; Cantero D Appl Microbiol Biotechnol; 2012 Apr; 94(1):163-71. PubMed ID: 22173483 [TBL] [Abstract][Full Text] [Related]
5. A comparative study on 1-nitropyrene and nitrofurazone reductases in Escherichia coli. Narai N; Kitamura S; Tatsumi K J Pharmacobiodyn; 1984 Jun; 7(6):407-13. PubMed ID: 6384469 [TBL] [Abstract][Full Text] [Related]
6. Oxygen-insensitive nitroreductase E. coli NfsA, but not NfsB, is inhibited by fumarate. Day MA; Jarrom D; Rajah N; Searle PF; Hyde EI; White SA Proteins; 2023 May; 91(5):585-592. PubMed ID: 36443029 [TBL] [Abstract][Full Text] [Related]
7. Characteristics of major Escherichia coli reductases involved in aerobic nitro and azo reduction. Mercier C; Chalansonnet V; Orenga S; Gilbert C J Appl Microbiol; 2013 Oct; 115(4):1012-22. PubMed ID: 23795903 [TBL] [Abstract][Full Text] [Related]
8. Residue Phe42 is critical for the catalytic activity of Escherichia coli major nitroreductase NfsA. Yang J; Zhan J; Bai J; Liu P; Xue Y; Yang Q Biotechnol Lett; 2013 Oct; 35(10):1693-700. PubMed ID: 23801116 [TBL] [Abstract][Full Text] [Related]
9. Biochemical characterization of NfsA, the Escherichia coli major nitroreductase exhibiting a high amino acid sequence homology to Frp, a Vibrio harveyi flavin oxidoreductase. Zenno S; Koike H; Kumar AN; Jayaraman R; Tanokura M; Saigo K J Bacteriol; 1996 Aug; 178(15):4508-14. PubMed ID: 8755878 [TBL] [Abstract][Full Text] [Related]
11. Steady-state and stopped-flow kinetic studies of three Escherichia coli NfsB mutants with enhanced activity for the prodrug CB1954. Jarrom D; Jaberipour M; Guise CP; Daff S; White SA; Searle PF; Hyde EI Biochemistry; 2009 Aug; 48(32):7665-72. PubMed ID: 19580253 [TBL] [Abstract][Full Text] [Related]
12. Incidence and Genetic Bases of Nitrofurantoin Resistance in Clinical Isolates of Two Successful Multidrug-Resistant Clones of Salmonella enterica Serovar Typhimurium: Pandemic "DT 104" and pUO-StVR2. García V; Montero I; Bances M; Rodicio R; Rodicio MR Microb Drug Resist; 2017 Jun; 23(4):405-412. PubMed ID: 27809653 [TBL] [Abstract][Full Text] [Related]
13. Oxygen-insensitive nitroreductases NfsA and NfsB of Escherichia coli function under anaerobic conditions as lawsone-dependent Azo reductases. Rau J; Stolz A Appl Environ Microbiol; 2003 Jun; 69(6):3448-55. PubMed ID: 12788749 [TBL] [Abstract][Full Text] [Related]
14. Nitrofurazone-reducing enzymes in E. coli and their role in drug activation in vivo. McCalla DR; Olive P; Tu Y; Fan ML Can J Microbiol; 1975 Oct; 21(10):1484-91. PubMed ID: 136 [TBL] [Abstract][Full Text] [Related]
15. Unravelling mechanisms of nitrofurantoin resistance and epidemiological characteristics among Escherichia coli clinical isolates. Zhang X; Zhang Y; Wang F; Wang C; Chen L; Liu H; Lu H; Wen H; Zhou T Int J Antimicrob Agents; 2018 Aug; 52(2):226-232. PubMed ID: 29753133 [TBL] [Abstract][Full Text] [Related]
16. Mutations to nitrofurantoin and nitrofurazone resistance in Escherichia coli K12. Breeze AS; Obaseiki-Ebor EE J Gen Microbiol; 1983 Jan; 129(1):99-103. PubMed ID: 6339681 [TBL] [Abstract][Full Text] [Related]
17. Development and analysis of furazolidone-resistant Escherichia coli mutants. Martínez-Puchol S; Gomes C; Pons MJ; Ruiz-Roldán L; Torrents de la Peña A; Ochoa TJ; Ruiz J APMIS; 2015 Aug; 123(8):676-81. PubMed ID: 26011027 [TBL] [Abstract][Full Text] [Related]
18. Mode of action of nitrofurazone. McCalla DR; Reuvers A; Kaiser C J Bacteriol; 1970 Dec; 104(3):1126-34. PubMed ID: 16559085 [TBL] [Abstract][Full Text] [Related]